Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Iclusig Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Iclusig Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 45mg
      • 1.3.3 15mg
    • 1.4 Market Segment by Application
      • 1.4.1 Global Iclusig Market Share by Application (2019-2025)
      • 1.4.2 CML
      • 1.4.3 ALL
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Iclusig Market Size
      • 2.1.1 Global Iclusig Revenue 2014-2025
      • 2.1.2 Global Iclusig Sales 2014-2025
    • 2.2 Iclusig Growth Rate by Regions
      • 2.2.1 Global Iclusig Sales by Regions 2014-2019
      • 2.2.2 Global Iclusig Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Iclusig Sales by Manufacturers
      • 3.1.1 Iclusig Sales by Manufacturers 2014-2019
      • 3.1.2 Iclusig Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Iclusig Revenue by Manufacturers (2014-2019)
      • 3.2.2 Iclusig Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Iclusig Market Concentration Ratio (CR5 and HHI)
    • 3.3 Iclusig Price by Manufacturers
    • 3.4 Key Manufacturers Iclusig Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Iclusig Market
    • 3.6 Key Manufacturers Iclusig Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 45mg Sales and Revenue (2014-2019)
      • 4.1.2 15mg Sales and Revenue (2014-2019)
    • 4.2 Global Iclusig Sales Market Share by Type
    • 4.3 Global Iclusig Revenue Market Share by Type
    • 4.4 Iclusig Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Iclusig Sales by Application

    6 United States

    • 6.1 United States Iclusig Breakdown Data by Company
    • 6.2 United States Iclusig Breakdown Data by Type
    • 6.3 United States Iclusig Breakdown Data by Application

    7 European Union

    • 7.1 European Union Iclusig Breakdown Data by Company
    • 7.2 European Union Iclusig Breakdown Data by Type
    • 7.3 European Union Iclusig Breakdown Data by Application

    8 China

    • 8.1 China Iclusig Breakdown Data by Company
    • 8.2 China Iclusig Breakdown Data by Type
    • 8.3 China Iclusig Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Iclusig Breakdown Data by Company
    • 9.2 Rest of World Iclusig Breakdown Data by Type
    • 9.3 Rest of World Iclusig Breakdown Data by Application
    • 9.4 Rest of World Iclusig Breakdown Data by Countries
      • 9.4.1 Rest of World Iclusig Sales by Countries
      • 9.4.2 Rest of World Iclusig Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 ARIAD Pharmaceuticals
      • 10.1.1 ARIAD Pharmaceuticals Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Iclusig
      • 10.1.4 Iclusig Product Introduction
      • 10.1.5 ARIAD Pharmaceuticals Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Iclusig Sales Channels
      • 11.2.2 Iclusig Distributors
    • 11.3 Iclusig Customers

    12 Market Forecast

    • 12.1 Global Iclusig Sales and Revenue Forecast 2019-2025
    • 12.2 Global Iclusig Sales Forecast by Type
    • 12.3 Global Iclusig Sales Forecast by Application
    • 12.4 Iclusig Forecast by Regions
      • 12.4.1 Global Iclusig Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Iclusig Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Iclusig is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia(ALL).
      In 2019, the market size of Iclusig is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Iclusig.

      This report studies the global market size of Iclusig, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Iclusig sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      ARIAD Pharmaceuticals
      ...

      Market Segment by Product Type
      45mg
      15mg

      Market Segment by Application
      CML
      ALL

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Iclusig status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Iclusig manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Iclusig are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now